A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin: The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

European Heart Journal

Volumn 23, Issue 15, 2002, Pages 1190-1201

  Hasdai, D ^a   Behar, S ^b   Wallentin, L ^c   Danchin, N ^d   Gitt, A K ^e   Boersma, E ^f   Fioretti, P M ^g   Simoons, M L ^f   Battler, Alexander ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d CHU NANCY BRABOIS   (France)

^e KLINIKUM LUDWIGSHAFEN   (Germany)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Management; Medication; Percutaneous coronary intervention; Prognosis; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MORPHINE; NITRATE; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; DEMOGRAPHY; ELECTROCARDIOGRAM; EUROPE; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PRIORITY JOURNAL; Q WAVE; SOUTHERN EUROPE; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; ELECTROCARDIOGRAPHY; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; HEALTH CARE SURVEYS; HEART DISEASES; HEMODYNAMIC PROCESSES; HUMANS; MALE; MEDITERRANEAN REGION; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; PROSPECTIVE STUDIES; REGISTRIES; REPERFUSION; SYNDROME;

EID: 0036701017     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2002.3193     Document Type: Article

References (21)

1. Bower TJ, Turner RM, Wood DA et al. A national survey of acute myocardial infarction and ischaemia (SAMII) in the UK: characteristics, management and in-hospital outcomes in women compared to men in patients under 70 years. Eur Heart J 2000; 21: 1458-63.
2. Collinson J, Flather MD, Fox KAA et al. Clinical outcomes, risk staratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21: 1450-7.
3. Anderson HV, Gibson RS, Stone PH et al. Management of unstable angina and non-Q wave myocardial infarction in the United States and Canada (the TIMI III Registry). Am J Cardiol 1997; 79: 1441-6.
4. Rosengren A, Spetz CL, Koster M, Hammar N, Alfredsson L, Rosen M. Sex differences in survival after acute myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register. Eur Heart J 2001; 22: 314-22.
5. Donges K, Schiele R, Gitt A et al. Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]). Am J Cardiol 2001; 87: 1039-44.
6. Danchin N, Vaur L, Genes N et al. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the 'real world': One-year results from a nationwide French survey. Circulation 1999; 99: 2639-44.
7. Gottlieb S, Goldbourt U, Boyko V et al. Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. Eur Heart J 2000; 21: 261-2.
8. Rogers WJ, Canto JG, Lambrew CT et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2, and 3. J Am Coll Cardiol 2000; 36: 2056-63.
9. Gurwitz JH, Col NF, Avorn NJ. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 1992; 268: 1417-22.
10. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708-13.
11. Yusuf F, Flather M, Pogue J et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998; 352: 507-14.
12. Task force on the management of acute myocardial infarction of the European Society of Cardiology. Acute myocardial infarction: prehospital and in-hospital management. Eur Heart J 1996; 17: 43-63.
13. Bertrand ME, Simoons ML, Fox KAA et al. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation. Eur Heart J 2000; 21: 1406-32.
14. Fox KAA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J 2000; 21: 1440-9.
15. 1994 National Hospital Discharge Survey. Washington, DC; U.S. National Center for Health Statistics, 1995.
16. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - A concensus document of the The Joint European Society of Cardiology/American College of Cardiology Committee for the Redifinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36: 959-69.
17. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at I year after an invasive compared with a non-invasive strategy in unstable coronary artery disease. Lancet 2000; 356: 9-16.
18. Cannon CP, Weintraub WS, Demopoulos LA et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001; 344: 1879-87.
19. Simoons ML. Effect of glycoprotein IIb/IIIa receptor blocker abciximab in patients with acute coronary syndromes without early coronary revascularisation: The GUSTO IV ACS randomised trial. Lancet 2001; 357: 1915-24.
20. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial. Lancet 2001; 357: 1905-14.
21. Granger CB. Strategies of patient care in acute coronary syndromes: Rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol 2000; 86 (12B): 4M-9M.